Pierre Beauparlant

2.0k total citations · 1 hit paper
25 papers, 1.6k citations indexed

About

Pierre Beauparlant is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Pierre Beauparlant has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Pierre Beauparlant's work include NF-κB Signaling Pathways (9 papers), Immune Response and Inflammation (6 papers) and interferon and immune responses (4 papers). Pierre Beauparlant is often cited by papers focused on NF-κB Signaling Pathways (9 papers), Immune Response and Inflammation (6 papers) and interferon and immune responses (4 papers). Pierre Beauparlant collaborates with scholars based in Canada, Australia and Spain. Pierre Beauparlant's co-authors include John Hiscott, Rongtuan Lin, Anne Roulston, Gordon C. Shore, Mark A. Wainberg, Sylvain Meloche, Constantin Makris, Daniel Goulet, Ricky W. Johnstone and Enrico O. Purisima and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Pierre Beauparlant

24 papers receiving 1.5k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

2007 538 citations Mai Nguyen, Richard Marcellus et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pierre Beauparlant Canada	16	874	495	394	329	196	25	1.6k
R. Michael Sramkoski United States	23	842 1.0×	405 0.8×	224 0.6×	294 0.9×	99 0.5×	42	1.6k
Fabienne Aillet Spain	16	998 1.1×	405 0.8×	376 1.0×	443 1.3×	204 1.0×	25	1.5k
James R. Zucali United States	19	593 0.7×	447 0.9×	263 0.7×	470 1.4×	94 0.5×	42	1.5k
Prem S. Subramaniam United States	30	977 1.1×	992 2.0×	291 0.7×	910 2.8×	160 0.8×	56	2.2k
Matthias Germer Germany	12	1.6k 1.8×	800 1.6×	370 0.9×	376 1.1×	283 1.4×	16	2.2k
L Tuel-Ahlgren United States	25	759 0.9×	652 1.3×	154 0.4×	375 1.1×	67 0.3×	35	1.9k
Sheng-Chung Lee Taiwan	28	1.3k 1.5×	357 0.7×	195 0.5×	297 0.9×	165 0.8×	51	2.2k
Ramesh B. Batchu United States	25	1.0k 1.2×	415 0.8×	199 0.5×	446 1.4×	137 0.7×	55	1.7k
James Greger United States	17	895 1.0×	261 0.5×	118 0.3×	615 1.9×	134 0.7×	28	1.5k
Didier Grillot United States	26	1.5k 1.7×	976 2.0×	355 0.9×	634 1.9×	176 0.9×	39	2.7k

Countries citing papers authored by Pierre Beauparlant

Since Specialization

Citations

This map shows the geographic impact of Pierre Beauparlant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Beauparlant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Beauparlant more than expected).

Fields of papers citing papers by Pierre Beauparlant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Beauparlant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Beauparlant. The network helps show where Pierre Beauparlant may publish in the future.

Co-authorship network of co-authors of Pierre Beauparlant

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Beauparlant. A scholar is included among the top collaborators of Pierre Beauparlant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Beauparlant. Pierre Beauparlant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beauparlant, Pierre, et al.. (2021). Skeletal Effects of Bone-Targeted TGFbeta Inhibition in a Mouse Model of Duchenne Muscular Dystrophy. Life. 11(8). 791–791.

Beauparlant, Pierre, Dominique Bédard, Cynthia Bernier, et al.. (2009). Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777. Anti-Cancer Drugs. 20(5). 346–354. 51 indexed citations

Roulston, Anne, Helen Chan, Daniel Goulet, et al.. (2008). 470 POSTER Target identification permits rational development of the prodrug GMX1777 for the treatment of melanoma. European Journal of Cancer Supplements. 6(12). 150–150. 1 indexed citations

Roulston, Anne, Mark H. Watson, Cynthia Bernier, et al.. (2007). GMX1777: a novel inhibitor of NAD+ biosynthesis via inhibition of nicotinamide phosphoribosyl transferase.. Molecular Cancer Therapeutics. 6. 2 indexed citations

Shore, Gordon C., Mark Watson, Anne Roulston, et al.. (2006). Obatoclax (GX15-070) Is a Potent Antagonist of Constitutive Mcl-1/Bak Interactions in Intact Mitochondrial Membrane and Synergizes with Bortezomib in Mantle Cell Lymphoma.. Blood. 108(11). 832–832. 4 indexed citations

Denisov, A. Yu., Gang Chen, Tara Sprules, et al.. (2006). Structural Model of the BCL-w−BID Peptide Complex and Its Interactions with Phospholipid Micelles^,. Biochemistry. 45(7). 2250–2256. 45 indexed citations

Olney, Harold J., et al.. (2005). Preclinical evaluation of apoptosis induction by the novel small molecule BCL-2 inhibitor, GX015–070, in ex vivo chronic lymphoid leukemia (CLL) cells. Journal of Clinical Oncology. 23(16_suppl). 3149–3149. 3 indexed citations

Beauparlant, Pierre, et al.. (2004). Bcl-2-targeted cancer therapeutics. Expert Opinion on Therapeutic Patents. 14(6). 805–818. 2 indexed citations

Beauparlant, Pierre & Gordon C. Shore. (2003). Therapeutic activation of caspases in cancer: a question of selectivity.. PubMed. 6(2). 179–87. 24 indexed citations

10.

Denisov, Alexei Yu., Murthy S.R. Madiraju, Gang Chen, et al.. (2003). Solution Structure of Human BCL-w. Journal of Biological Chemistry. 278(23). 21124–21128. 93 indexed citations

11.

Beauparlant, Pierre, Kim Papp, & Boulos Haraoui. (1999). The incidence of cancer associated with the treatmentof rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 29(3). 148–158. 66 indexed citations

12.

Lee, Raymond, Pierre Beauparlant, Howard L. Elford, Přemysl Poňka, & John Hiscott. (1997). Selective Inhibition of IκBα Phosphorylation and HIV-1 LTR-Directed Gene Expression by Novel Antioxidant Compounds. Virology. 234(2). 277–290. 48 indexed citations

13.

Beauparlant, Pierre & John Hiscott. (1996). Biological and biochemical inhibitors of the NF-κB/Rel proteins and cytokine synthesis. Cytokine & Growth Factor Reviews. 7(2). 175–190. 120 indexed citations

14.

Lin, Rongtuan, Pierre Beauparlant, Constantin Makris, Sylvain Meloche, & John Hiscott. (1996). Phosphorylation of IκBα in the C-Terminal PEST Domain by Casein Kinase II Affects Intrinsic Protein Stability. Molecular and Cellular Biology. 16(4). 1401–1409. 186 indexed citations

15.

Beauparlant, Pierre, Rongtuan Lin, & John Hiscott. (1996). The Role of the C-terminal Domain of IκBα in Protein Degradation and Stabilization. Journal of Biological Chemistry. 271(18). 10690–10696. 32 indexed citations

16.

Beauparlant, Pierre, Hakju Kwon, M Clarke, et al.. (1996). Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Journal of Virology. 70(9). 5777–5785. 44 indexed citations

17.

Bitar, Richard, et al.. (1995). Retrovirus-mediated transfer of nuclear factor-kappa B subunit genes modulates I kappa B alpha and interferon beta expression.. PubMed. 6(8). 965–76. 8 indexed citations

18.

Roulston, Anne, Rongtuan Lin, Pierre Beauparlant, Mark A. Wainberg, & John Hiscott. (1995). Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. Microbiological Reviews. 59(3). 481–505. 139 indexed citations

19.

Beauparlant, Pierre, et al.. (1994). Radioimmunoprecipitation in the diagnosis of chronic active epstein‐barr virus infection. Journal of Medical Virology. 42(3). 241–246. 1 indexed citations

20.

Beauparlant, Pierre, et al.. (1990). The Diagnosis of Epstein‐Barr Virus‐Associated Polymorphic B Cell Lymphoma in Immunocompromised Patients: Review of Methods. Canadian Journal of Infectious Diseases and Medical Microbiology. 2(3). 109–115. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact